Postoperative Course in 7 Cases of Primary Sarcoma of the Lung

Corpa-Rodríguez, M.E.; Mayoralas-Alises, S.; García-Sánchez, J.; Gil-Alonso, J.L.; Díaz-Agero, P.; Casillas-Pajuelo, M.

doi:10.1016/S1579-2129(06)60298-X

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is a scientific journal that preferentially publishes prospective original research articles whose content is based upon results dealing with several aspects of respiratory diseases such as epidemiology, pathophysiology, clinics, surgery, and basic investigation. Other types of articles such as reviews, editorials, a few special articles of interest to the society and the editorial board, scientific letters, letters to the Editor, and clinical images are also published in the Journal. It is a monthly Journal that publishes a total of 12 issues and a few supplements, which contain articles belonging to the different sections.

All the manuscripts received in the Journal are evaluated by the Editors and sent to expert peer-review while handled by the Editor and/or an Associate Editor from the team. The Journal is published monthly in English.

Manuscripts will be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/, link which is also accessible through the main web page of Archivos de Bronconeumologia.

Access to any published article, is possible through the Journal's web page as well as from PubMed, Science Direct, and other international databases. Furthermore, the Journal is also present in Twitter and Facebook. The Journal expresses the voice of the Spanish Respiratory Society of Pulmonology and Thoracic Surgery (SEPAR) as well as that of other scientific societies such as the Latin American Thoracic Society (ALAT) and the Iberian American Association of Thoracic Surgery (AICT).

Authors are also welcome to submit their articles to the Journal's open access companion title, Open Respiratory Archives.

Archivos de Bronconeumologia has received the new Impact Factor (JCR). The impact factor has risen from 6.333 in 2021 to 8 in the last evaluated year, 2022.
It is needed to be a member of SEPAR or have a subscription to access full texts of articles published last year. Abstracts are available for all visitors.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

2.8

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.434

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.437

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 41. Issue 11.

Pages 634-637 (November 2005)

More article options

Pages 634-637 (November 2005)

Case Reports

DOI: 10.1016/S1579-2129(06)60298-X

Full text access

Postoperative Course in 7 Cases of Primary Sarcoma of the Lung

Visits

3550

Download PDF

M.E. Corpa-Rodríguez

Corresponding author

ctoracica.hulp@salud.madrid.org

Correspondence: Dra. M.E. Corpa-Rodríguez. Servicio de Cirugía Torácica. Hospital Universitario La Paz. P.° de la Castellana, 261. 28046 Madrid. España

, S. Mayoralas-Alises, J. García-Sánchez, J.L. Gil-Alonso, P. Díaz-Agero, M. Casillas-Pajuelo

Servicio de Cirugía Torácica, Hospital Universitario La Paz, Madrid, Spain

This item has received

3550 Visits

Article information

Abstract

Bibliography

Download PDF

Statistics

Unlike lung metastases of extrapulmonary sarcomas, primary sarcoma of the lung is very rare. We analyzed 7 primary sarcomas treated surgically in Hospital Universitario La Paz, Madrid, Spain between 1985 and 2001. Preoperative histologic diagnosis was correct for 2 patients. Surgery was performed in all 7 patients. Resection was extended to the left atrium in 1 patient, to the chest wall in another, and the parietal pleura were removed from 2 others. Surgical resection was considered complete in 6 cases. Histology revealed 4 cases of malignant fibrous histiocytoma, 1 angiosarcoma, 1 osteogenic sarcoma, and 1 undifferentiated sarcoma. Enlarged lymph nodes removed during surgery were tumor free.

Three patients received complementary treatment. The 3 longest-surviving patients were treated with surgery alone; at the end of the study, these patients remained alive 16, 9, and 4 years after surgery. One patient has a recurrent lymph node tumor in a single lung. Three patients died within 1 year and another died 24 months after surgery. In conclusion, surgical treatment of primary sarcoma of the lung can achieve good survival.

Key Words:

Lung sarcoma

Malignant fibrous histiocytoma

Angiosarcoma

Los sarcomas primitivos pulmonares son muy raros, pero no los metastásicos. Se analizaron 7 sarcomas primarios operados en nuestro servicio entre 1985 y 2001. El diagnósti-co histológico preoperatorio fue correcto en 2 pacientes. Se realizó cirugía en todos. En uno se amplió la resección a aurícula izquierda, en otro a pared torácica y en otros 2 se ex-tirpó pleura parietal. Se consideró cirugía completa en 6 ca-sos. En el estudio histológico 4 fueron fibrohistiocitomas malignos, uno angiosarcoma, uno sarcoma osteogénico y uno sarcoma indiferenciado. Las adenopatías extirpadas es-taban libres de tumor.

Se hizo tratamiento complementario en 3 pacientes. En los 3 de mayor supervivencia se realizó sólo cirugía, con un seguimiento de 16, 9 y 4 años, respectivamente. Uno tiene actualmente una recidiva tumoral nodular en pulmón ünico. En cuanto a los fallecidos, 3 murieron antes de un año y otro después de 24 meses de evolución.

En conclusión, la cirugía en los sarcomas pulmonares primitivos puede conseguir una elevada supervivencia.

Palabras clave:

Sarcomas pulmonares

Fibrohistiocitoma malig-no

Angiosarcoma

Full text is only aviable in PDF

REFERENCES

[1]

N Martini, SI Hadju, EJ Beattie Jr.

Primary sarcoma of the lung.

J Thorac Cardiovasc Surg, 61 (1971), pp. 33-38

Medline

[2]

JG Guecion, SH Rosen.

Bronchopulmonary leiomyosarcoma and fibrosarcoma. A study of 32 cases and review of the literature.

Cancer, 30 (1972), pp. 836-847

Medline

[3]

Robison PG, Shields TW. Uncommon primary malignant tumors of the lung. In: Shields TW, Locicero J III, Ponn RB, editors. General thoracic surgery. 5th ed. Philadelphia: Lippincott Williams & Wilkins; p. 1533-53.

[5]

PM McCormack, N Martini.

Primary sarcomas and lymphomas of lung.

[6]

JP Janssen, JS Mulder, S Wagenaar, et al.

Primary sarcoma of the lung: a clinical study with long-term follow-up.

Ann Thorac Surg, 58 (1994), pp. 1151-1155

[7]

JT Lee, JD Shelburne, J Linder.

Primary malignant fibrous histiocytoma of the lung. A clinicopathologic and ultrastructural study of five cases.

Cancer, 53 (1984), pp. 1124-1130

Medline

[8]

MY Halyard, JK Camoriano, JA Culligan, LH Weiland, MD Allen, JR Pluth, et al.

Malignant fibrous histiocytoma of the lung.

Cancer, 78 (1996), pp. 2492-2497

[9]

JF Régnard, P Icard, L Guibert, VT de Montpreville, P Magdeleinat, P Levasseur.

Prognostic factors and result after surgical treatment of primary sarcomas of the lung.

Ann Thorac Surg, 68 (1999), pp. 227-231

Medline

[10]

RL Attanoos, MACA Appleton, AR Gibbs.

Primary sarcomas of the lung: a clinicopathological and immunohistochemical study of 15 cases.

Histopathology, 29 (1996), pp. 29-36

Medline

[11]

HL Porte, DG Metois, X Leroy, M Conti, B Gosselin, A Wurtz.

Surgical treatment of primary sarcoma of the lung.

Eur J Cardiothorac Surg, 18 (2000), pp. 136-142

Medline

[12]

EA Bacha, CD Wright, HC Grillo, JC Wain, Moncure A, SB Keel, et al.

Surgical treatment of primary pulmonary sarcomas.

Eur J Cardiothorac Surg, 15 (1999), pp. 456-460

Medline

[13]

A Ríos Zambundio, MJ Roca Calvo, LA Polo García.

Fibrohistiocitoma maligno de pulmón variedad estoriforme.

Arch Bronconeumol, 39 (2003), pp. 431-432

[14]

Burt M, Zakowski M. Rare primary malignant neoplasms. In: Pearson FG, Deslauriers J, Ginsberg RJ, Hiebert CA, McKneally MF, Urschel HC Jr, editors. Thoracic surgery. p. 807-26.

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter